Upadacitinib will be administered as oral tablet.
Other Name: ABT-494
- The participant must not be eligible for upadacitinib clinical trial.
ABBVIE CALL CENTER
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.